Adicet Bio, Inc.

NasdaqCM:ACET Stock Report

Market Cap: US$69.5m

Adicet Bio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ACET Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Oct 25BuyUS$5,000,000OrbiMed Advisors LLCCompany312,500US$16.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ACET?
Owner TypeNumber of SharesOwnership Percentage
Public Companies60,5110.563%
Individual Insiders84,4740.786%
Hedge Funds625,0005.81%
VC/PE Firms1,976,19318.4%
Institutions3,867,08136%
General Public4,135,98138.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 88.7%.


Top Shareholders

Top 25 shareholders own 59.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.56%
OrbiMed Advisors LLC
1,027,944US$6.7m43.7%0.1%
8.82%
RA Capital Management, L.P.
948,249US$6.1m101%0.07%
5.83%
Franklin Resources, Inc.
626,571US$4.1m0%no data
5.81%
Woodline Partners LP
625,000US$4.0m0%0.02%
2.71%
The Vanguard Group, Inc.
291,277US$1.9m42.4%no data
2.55%
Adage Capital Management, L.P.
274,375US$1.8m0%no data
2.33%
Prosight Management, LP
250,244US$1.6m0%0.34%
2.26%
Renaissance Technologies LLC
242,945US$1.6m113%no data
2.18%
The Goldman Sachs Group, Inc.
234,510US$1.5m0.01%no data
2.05%
Stonepine Capital Management LLC
220,011US$1.4m0%0.82%
1.9%
Alyeska Investment Group, L.P.
203,799US$1.3m397%no data
1.71%
Abingworth LLP
184,295US$1.2m0%2.15%
1.69%
Acadian Asset Management LLC
181,395US$1.2m28.1%no data
1.47%
Nextbio Capital Management Lp
157,827US$1.0m0%0.56%
1.35%
Two Sigma Investments, LP
144,796US$936.8k171%no data
1.2%
ADAR1 Capital Management, LLC
128,646US$832.3k0%0.07%
1.04%
Two Sigma Advisers, LP
111,336US$720.3k128%no data
1%
Citadel Advisors LLC
107,814US$697.6k195%no data
0.87%
Dafna Capital Management, LLC
93,812US$607.0k0%0.15%
0.83%
Geode Capital Management, LLC
88,856US$574.9k101%no data
0.58%
Burkehill Global Management, LP
62,500US$404.4k0%0.03%
0.56%
Regeneron Pharmaceuticals, Inc.
60,511US$391.5k0%no data
0.55%
Luminus Management, LLC
59,558US$385.3k0%0.29%
0.52%
Bridgeway Capital Management, LLC
56,350US$364.6k0%0.01%
0.52%
Squarepoint OPS LLC
55,723US$360.5k1,820%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/29 15:41
End of Day Share Price 2026/03/27 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adicet Bio, Inc. is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Justin ZelinB. Riley Securities, Inc.
John NewmanCanaccord Genuity
Yatin SunejaGuggenheim Securities, LLC